SMITHS FALLS, ON and NEW YORK, Sept. 14, 2021 /PRNewswire/ – Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Company”), a world-leading diversified cannabis, hemp, and vaporization company, today announced the launch of the company’s first-ever CBD vape, whisl. This sleek, nicotine-free CBD vaporizer is designed to deliver the wellness effects of CBD from morning, throughout the day and into the night.
With an innovative design that incorporates custom, interchangeable pods, whisl offers three uniquely formulated options to help consumers dial in to their desired effect – focus, calm, or winding down before bed – as their needs and activities shift throughout the day.
“At Canopy Growth, we are pioneering the concept of using CBD to help consumers manage their moods at any given time of day,” said Andy Lytwynec, Vice President, Global Vape Business at Canopy Growth. “With whisl, we want to empower consumers to quickly achieve focus, calmness or prepare for sleep with a modern CBD solution that is fast-acting and can fit seamlessly into anyone’s daily routine.”
Each whisl pod contains 200 mg of premium CBD isolate, a purified form of CBD, sourced from licensed hemp providers within the United States and no THC. whisl devices come in two sleek colorways – Warm Grey and Deep Blue – and feature a rechargeable aluminum battery and a host of industry-leading safety and quality features.
Through an exclusive partnership, whisl will be available on store shelves at 3,000+ Circle K convenience stores nationwide beginning October 1 – marking Canopy Growth’s largest national retail launch yet. With an MSRP of $39.99 for the starter kit and $19.99 per package, whisl delivers an effective way to harness CBD wellness at an accessible price point. Beginning today, whisl is also available for purchase online at Canopy Growth’s one-stop U.S. ecommerce destination, www.shopcanopy.com.
For more information about whisl, visit www.enjoywhisl.com.
About Canopy Growth Corporation
Canopy Growth (TSX:WEED,NASDAQ:CGC ) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp-derived CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit http://www.canopygrowth.com/.
Notice Regarding Forward Looking Statements
This press release contains “forward-looking statements” and “forward-looking information” within the meaning of applicable U.S. and Canadian securities laws (collectively, “forward-looking statements”), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use of such terms and phrases as “intend,” “goal,” “strategy,” “estimate,” “expect,” “project,” “projections,” “forecasts,” “plans,” “seeks,” “anticipates,” “potential,” “proposed,” “will,” “should,” “could,” “would,” “may,” “likely,” “designed to,” “foreseeable future,” “believe,” “scheduled” and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward–looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward–looking statements and the forward–looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation (“Canopy”) can be found under the section entitled “Risk Factors” in Canopy’s Annual Report on Form 10-K for the year ended March 31, 2021, filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at www.sec.gov/edgar and www.sedar.com, respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward–looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward–looking statement. Readers are cautioned not to put undue reliance on any forward–looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Comments